2005093
print

Opiates, Urine Screen with Reflex to Quantitation

OPI RFX UR
Example Reports
Negative
Positive

Ordering Recommendation

Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out opiate exposure. For follow-up testing of a presumptive result, Opiates, Urine, Quantitative (0090364) is preferred.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Random urine.

Specimen Preparation

Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 2 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Specimens exposed to repeated freeze/thaw cycles.

Remarks
Stability

Ambient: 1 week; Refrigerated: 1 month; Frozen: 1 month

Methodology

Qualitative Enzyme Immunoassay/Quantitative Liquid Chromatography-Tandem Mass Spectrometry

Performed

Sun-Sat

Reported

1-4 days

Reference Interval

Effective May 16, 2011

Screen cutoff concentration: 300 ng/mL

Interpretive Data

The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies. Specimens for which drugs or drug classes are detected by the screen are reflexed to a second, more specific technology (GC/MS and/or LC-MS/MS). The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

For medical purposes only; not valid for forensic use.

Compliance Category

FDA

Note

This test detects morphine, hydrocodone, and similar compounds. The confirmation test detects and quantifies morphine, codeine, hydrocodone, hydromorphone, 6-monoacetylmorphine, oxycodone and oxymorphone.

If the specimen screens positive, then Confirmation/Quantitation by LC-MS/MS (ARUP test 0090364) will be added to confirm result. Additional charges apply.

For detection of oxycodone and/or oxymorphone, order Oxycodone/Oxymorphone Screen with Reflex to Confirmation, Urine (ARUP test code 2005100).

Hotline History

N/A

CPT Codes

80307; if reflexed, add 80361; 80365 (Reflexed Alt Code: G0480 )

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
2005094 Opiates, Urn, Screen 19295-5
2012212 Screen, Urine Interpretation 54247-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Opiates urine concentration
  • Pain Management, Opiates, Quantitative, Urine
  • Urine screen and confirmation for opiates
Opiates, Urine Screen with Reflex to Quantitation